This content is 9 years old. Content may be out of date.

Newsletter July 2012

21 Feb 2015
WWARN Published Date
  • Imagen eliminada.·         WWARN addresses a major challenge in containing antimalarial resistance: the need for accessible and reliable information to halt the proliferation of substandard or falsified drugs. Discover the Antimalarial Quality (AQ) Surveyor, the first open access, independent, global repository of antimalarial quality data.
  • ·         Recent stakeholders meetings organized by the WWARN East and West Africa Regional Centres debated research on antimalarial resistance, agreeing there cannot be a 'one size fits all' model for the continent.
  • ·         WWARN is creating global resources to identify and track resistance in P vivax, including developing protocols for determining antimalarial efficacy.
  • ·         Read the interview with Prof Arjen Dondorp, Chair of the World Health Organization Technical Expert Group on Antimalarial Drug Resistance and Containment whose initial focus is on the artemisinin resistance containment programme.